South Dakota Investment Council Has $534,000 Position in HCA Healthcare, Inc. $HCA

South Dakota Investment Council trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 54.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,128 shares of the company’s stock after selling 1,360 shares during the quarter. South Dakota Investment Council’s holdings in HCA Healthcare were worth $534,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. boosted its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV boosted its position in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares during the period. Anchyra Partners LLC grew its stake in HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd lifted its stake in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on HCA shares. The Goldman Sachs Group lowered their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday. Argus cut their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Stephens dropped their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Morgan Stanley reduced their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday. Finally, KeyCorp cut their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.05.

HCA Healthcare Stock Performance

Shares of HCA opened at $403.44 on Friday. HCA Healthcare, Inc. has a 52 week low of $353.13 and a 52 week high of $556.52. The stock has a 50 day moving average price of $387.06 and a two-hundred day moving average price of $451.16. The firm has a market capitalization of $87.35 billion, a P/E ratio of 13.51, a P/E/G ratio of 1.37 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the firm earned $6.84 earnings per share. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.